Contura Orthopedics Expands to Canada, Bringing Arthrosamid® to North America

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Arthrosamid-Contura

More Like This

PR Newswire associated0

Amacathera Collaborates With Leading Global Pharmaceutical Company To Develop Single-Injection, Long-Acting Biologic Using Its Advanced Hydrogel Delivery Platform, Amacagel™

PR Newswire associated0

ReCerf Receives its CE Mark, Advancing Access to Ceramic Hip Resurfacing Across Europe

PR Newswire associated0

AmacaThera doses First In Human Study to Evaluate, AMT-143, for Non-opioid Treatment of Post-operative Pain

Nanochon Announces Health Canada Approval for First in Human Investigation

PR Newswire associated0

ReCerf® Hip Resurfacing Arthroplasty, from MatOrtho® Becomes the World's First All-Ceramic Hip Resurfacing Approved by a Regulatory Authority

Galderma Announces Triple Approval of New State-of-the-Art Restylane® Syringe in the EU, the U.S., and Canada, Reaffirming the Company’s Position at the Forefront of Injectable Aesthetics

No serious adverse events to date in ongoing phase 1/2a clinical study of SYN321

IMCAS 2026: Galderma Showcases the Latest Scientific Advances Behind the Industry’s Broadest Injectable Aesthetics Portfolio